Related Experiment Videos
Long noncoding RNA LINC00337 accelerates the non-small-cell lung cancer progression through inhibiting TIMP2 by
Xiaodong Zhang1, Jun Gong1, Junguo Lu1
1Department of Medical Oncology, Nantong Tumor Hospital Nantong 226006, Jiangsu Province, China.
Abstract:
Accumulating evidence reveals the essential roles of long noncoding RNAs (lncRNAs) in the non-small-cell lung cancer (NSCLC) tumorigenesis. Here, our research investigated the biological roles of novel lncRNA LINC00337 in the NSCLC tumorigenesis and discover the potential mechanism. In the NSCLC tissue and cell lines, LINC00337 was found to be remarkedly up-regulated, and the ectopic LINC00337 overexpression indicated the poor survival of NSCLC patients. In vitro, gain and loss of functional assays showed that LINC00337 promoted the progression of NSCLC cells, including proliferation and invasion. In vivo, LINC00337 knockdown inhibited the tumor growth of NSCLC cells. Mechanically, LINC00337 could recruit the epigenetic repressor DNMT1 to the promoter region of TIMP2 to silence its expression. In conclusion, our study found the critical regulation of lncRNA LINC00337 for the NSCLC through epigenetic regulation, which may serve as a predictive biomarker and potential therapeutic target.
Insights
This study identifies long noncoding RNA LINC00337 as a key driver in non-small-cell lung cancer (NSCLC) progression. Upregulation of LINC00337 promotes NSCLC cell proliferation and invasion via epigenetic silencing of TIMP2.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Long noncoding RNAs (lncRNAs) play crucial roles in cancer development.
- Non-small-cell lung cancer (NSCLC) is a major cause of cancer-related mortality.
- The specific functions of many lncRNAs in NSCLC remain largely unexplored.
Purpose of the Study:
- To investigate the role of the novel lncRNA LINC00337 in non-small-cell lung cancer (NSCLC) tumorigenesis.
- To elucidate the underlying molecular mechanism of LINC00337 action in NSCLC.
- To assess LINC00337 as a potential diagnostic biomarker and therapeutic target for NSCLC.
Main Methods:
- Analysis of LINC00337 expression in NSCLC tissues and cell lines.
- In vitro functional assays (proliferation, invasion) following LINC00337 manipulation.
- In vivo tumor growth assays after LINC00337 knockdown.
- Mechanistic studies involving DNMT1 recruitment and TIMP2 promoter activity.
Main Results:
- LINC00337 is significantly upregulated in NSCLC tissues and associated with poor patient survival.
- Overexpression of LINC00337 enhances NSCLC cell proliferation and invasion.
- Knockdown of LINC00337 inhibits tumor growth in vivo.
- LINC00337 epigenetically silences TIMP2 by recruiting DNMT1 to its promoter.
Conclusions:
- LINC00337 acts as an oncogenic lncRNA in NSCLC progression.
- The LINC00337/DNMT1/TIMP2 axis represents a novel epigenetic regulatory mechanism in NSCLC.
- LINC00337 holds potential as a predictive biomarker and therapeutic target for NSCLC patients.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...